Donald Trump has flagged a tariff on the pharmaceutical sector, which to date has been on the exempt goods list.

It’s well-worn but it is worth repeating Warren Buffett’s advice to be greedy when others are fearful and fearful when others are greedy.

ASX takes a beating as US-China trade war escalates, but biotech and rare earth stocks shine despite uncertain market ...

With critical minerals becoming ever more important, Saskatchewan has all the right ingredients to be a major player.

A price turnaround and the prospect of accelerated rate cuts puts residential property back in favour as share markets turn ...

Firetail Resources (ASX:FTL) moves to refine porphyry potential at Picha project with field programs and geophysics ...

A big mover among small caps was Leeuwin Metals after a review of drilling at Marda gold project pointed to extensive mineralisation.

Having won US Food & Drug Administration approval for its nerve repair agent Remplir, Orthocell is wasting no time getting it ...

Tony Locantro takes in the shockwaves of the Trump tariffs and goes into how he plans on navigating through the chaos.

ASX cops a beating as the US-China trade spat rocks markets, pharma faces tariff pain, oil dives, and Aussie miners take a hit.

GTI Energy (ASX:GTR) is nearing completion of its interim scoping study at the Lo Herma in situ recovery uranium project in Wyoming.

Maronan’s (ASX:MMA) high-grade copper-gold results in the shallow Starter Zone could present early mining options for its namesake project.